Glenmark Pharma Gets U.S. FDA Warning Letter Over Baddi Unit   
An employee operates a filtration machine inside a laboratory. (Photographer: Sara Hylton/Bloomberg)

Glenmark Pharma Gets U.S. FDA Warning Letter Over Baddi Unit   

Glenmark Pharmaceuticals Ltd. received a warning letter from the U.S. Food and Drug Administration for its Baddi facility in Himachal Pradesh.The company is committed to working along with the regu...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.